Jul 28, 2026
From August 5 to 7, 2026, an industry event themed “Building a Nucleic Acid Industry Ecosystem, Ushering in a New Era of Pharmaceutical Development” will be held at the InterContinental Hotel in Yujiapu, Tianjin.
At the event, Synthgene showcase key raw materials and technical services for nucleic acid therapeutics at Booth B10. During the exhibition, Dr. Wang Xingxing, Vice President of Synthgene’s Nucleic Acid Business Division, will be invited to attend the conference. He will not only deliver a keynote presentation but also participate in a roundtable forum to discuss hot topics such as Ab-LNP technological innovation, the industrialization of mRNA therapeutics, and the commercialization of delivery systems with industry experts.
Presentation Time: August 7, 2026, 9:30–9:50 a.m.
Venue: Breakout Session 4: Industrialization of mRNA Drugs
Presentation Title: Ab-LNP One-Stop Characterization Services to Support the Industrialization of In Vivo CAR-T Therapy
Roundtable Discussion: Breaking Through Commercialization Challenges for mRNA Drugs and Delivery Systems
The report will focus on the key characterization requirements and technical solutions for the Ab-LNP delivery system. Drawing on industry trends, it will discuss how a systematic characterization platform can enhance R&D efficiency and provide robust support for the development and commercialization of cutting-edge therapies such as in vivo CAR-T.
Conference Dates: August 5–7, 2026
Venue: InterContinental Tianjin Yujiapu (20 meters due south of 3360 Xinhua Road, Binhai New Area, Tianjin)
Booth: B10
